In clinical trials, the most common dosage of RYR is 600 mg twice daily. This dose has demonstrated effectiveness for reducing LDL cholesterol, improving atherosclerosis, and lowering the risk of major adverse cardiac events.^[3][4][5] Importantly, most clinical trials have used a traditional Chinese medicine standardized extract, Xuezhikang. At a dose of 600 mg twice daily, Xuexhikang would provide about 10 mg daily of the active compound monacolin K, which is suggested to be the adequate amount for reducing LDL cholesterol.^[6][7] Ultimately, most supplements don’t disclose the amount of monacolin K they contain, which makes it challenging to ensure adequate doses are achieved.